What health tech startups can expect in 2025news2024-12-19T16:48:39+00:00December 19th, 2024|Endpoints News|
Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drugnews2024-12-19T15:49:02+00:00December 19th, 2024|Endpoints News|
In blow to compounders, FDA reaffirms tirzepatide shortage is overnews2024-12-19T15:36:52+00:00December 19th, 2024|Endpoints News|
Lonza expands capsule footprint; BioCentriq’s new HQnews2024-12-19T15:15:21+00:00December 19th, 2024|Endpoints News|
Bristol Myers pays $100M upfront to collaborate with Leqembi originator in Alzheimer’snews2024-12-19T15:13:10+00:00December 19th, 2024|Endpoints News|
Sorriso claims a Phase 1b success for oral antibody in ulcerative colitisnews2024-12-19T15:00:07+00:00December 19th, 2024|Endpoints News|
Health tech industry predicts cautious funding optimism in 2025news2024-12-19T14:30:21+00:00December 19th, 2024|Endpoints News|
Endpoints winners and losers 2024: Best and worst biotech trendsnews2024-12-19T14:00:55+00:00December 19th, 2024|Endpoints News|
Updated: Vertex’s non-opioid pill disappoints in mid-stage chronic pain studynews2024-12-19T12:21:09+00:00December 19th, 2024|Endpoints News|
Ex-Color Health execs raise $10M to bring AI to pharmanews2024-12-19T12:00:18+00:00December 19th, 2024|Endpoints News|
